1 Correction to: Natural Products and Bioprospecting (2020) 10:131–140 https://doi.org/10.1007/s13659-020-00240-6

In the original publication of this article, we found an error under the section “Introduction”. The first sentence of the fourth paragraph appears incorrectly. The corrected sentence is given below.

Eriocalyxin B, isolated and identified in 1982 [1], is the major component in Chinese plant Isodon eriocalyx (Dunn.) Hara (family Lamiaceae) showing many pharmacological activities, such as inhibiting inflammatory response, regulating immune cell differentiation, inhibiting tumor cells proliferation, causing cell cycle arrest affecting angiogenesis and promoting cancer cells apoptosis.